Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP1948 monotherapy dose-escalation study in Japanese participants
jRCT2080224888Phase 1Completed
- Sponsor
- Astellas Pharma
- Start
- Sep 2019
- Modality
- Immune Checkpoint Inhibitors → Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 1, open-label trial of ASP1948 in Nonhematologic neoplasms (3 arms), sponsored by Astellas Pharma. Started Sep 2019; status: completed.
02
Drugs
ASP1948
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on jRCT2080224888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224888.